373 related articles for article (PubMed ID: 1384148)
1. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer.
Buxton EJ
Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer.
Tobias J; Buxton EJ; Blackledge G; Mould JJ; Monaghan J; Spooner D; Chetiyawardana A
Cancer Chemother Pharmacol; 1990; 26 Suppl():S59-62. PubMed ID: 1693316
[TBL] [Abstract][Full Text] [Related]
3. The role of ifosfamide in cervical cancer.
Buxton EJ; Blackledge G; Mould JJ; Monaghan J; Paterson M; Tobias J; Alcock C; Spooner D; Meanwell CA
Semin Oncol; 1989 Feb; 16(1 Suppl 3):60-7. PubMed ID: 2468183
[TBL] [Abstract][Full Text] [Related]
4. A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix.
Herod J; Burton A; Buxton J; Tobias J; Luesley D; Jordan S; Dunn J; Poole CJ
Ann Oncol; 2000 Sep; 11(9):1175-81. PubMed ID: 11061615
[TBL] [Abstract][Full Text] [Related]
5. The addition of bleomycin and dose-escalated ifosfamide to the combination of cisplatin plus ifosfamide does not improve survival in advanced or recurrent cervical carcinoma.
Hempling RE; Eltabbakh GH; Piver MS; Recio FO; O'Neill CP
Am J Clin Oncol; 1997 Jun; 20(3):315-8. PubMed ID: 9167762
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
Zanetta G; Fei F; Mangioni C
Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
[TBL] [Abstract][Full Text] [Related]
7. Bleomycin, cisplatinum and ifosfamide infusion chemotherapy in advanced/recurrent cancer of cervix.
Singhal RM; Jindel R; Gupta AK
Indian J Cancer; 1993 Dec; 30(4):158-63. PubMed ID: 7515843
[TBL] [Abstract][Full Text] [Related]
8. Primary chemotherapy with bleomycin, ifosfamide and cisplatinum (BIP) followed by radiotherapy in the treatment of advanced cervical cancer. A pilot study.
Nevin J; Bloch B; Van Wijk L; Soeters R; Dehaeck K; Ball H; Denny L
Eur J Gynaecol Oncol; 1995; 16(1):30-5. PubMed ID: 7538080
[TBL] [Abstract][Full Text] [Related]
9. The role of ifosfamide and systemic therapy in the management of carcinoma of the cervix.
Thigpen T; Vance R; Khansur T; Malamud F
Semin Oncol; 1996 Jun; 23(3 Suppl 6):56-64. PubMed ID: 8677451
[TBL] [Abstract][Full Text] [Related]
10. Phase II studies of bleomycin, ifosfamide and cis-platinum in advanced and recurrent cervical carcinoma.
Buxton EJ; Meanwell CA; Mould JJ; Latief T; Chetiyawardana AD; Spooner D; Tobias JS; Sokal M; Alcock C; Hilton C
Acta Oncol; 1988; 27(5):545-9. PubMed ID: 2462439
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study.
Kumar L; Kaushal R; Nandy M; Biswal BM; Kumar S; Kriplani A; Singh R; Rath GK; Kochupillai V
Gynecol Oncol; 1994 Sep; 54(3):307-15. PubMed ID: 7522200
[TBL] [Abstract][Full Text] [Related]
12. Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer.
Buxton EJ; Meanwell CA; Hilton C; Mould JJ; Spooner D; Chetiyawardana A; Latief T; Paterson M; Redman CW; Luesley DM
J Natl Cancer Inst; 1989 Mar; 81(5):359-61. PubMed ID: 2464699
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of ifosfamide, carboplatin and cisplatin in advanced and recurrent squamous cell carcinoma of the uterine cervix.
Filtenborg TA; Hansen HH; Aage Engelholm S; Rørth M
Ann Oncol; 1993 Jun; 4(6):485-8. PubMed ID: 8353091
[TBL] [Abstract][Full Text] [Related]
14. Combined chemotherapy using cisplatin, ifosfamide and bleomycin (PIB) in the treatment of advanced and recurrent cervical carcinoma.
Tay SK; Lai FM; Soh LT; Ho TH; Ang PT; Au E
Aust N Z J Obstet Gynaecol; 1992 Aug; 32(3):263-6. PubMed ID: 1280100
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study.
Bloss JD; Blessing JA; Behrens BC; Mannel RS; Rader JS; Sood AK; Markman M; Benda J
J Clin Oncol; 2002 Apr; 20(7):1832-7. PubMed ID: 11919241
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide, adriamycin and cisplatin (IAP) plus bleomycin (B) combination chemotherapy in patients with recurrent cancer of the uterine cervix.
Nishida T; Nagasue N; Arimatsu T; Nagano H; Izumi S; Okura N; Matsumura T; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):590-4. PubMed ID: 2474043
[TBL] [Abstract][Full Text] [Related]
17. Bleomycin-ifosfamide-cis-platinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: a second look.
Ramm K; Vergote IB; Kaern J; Tropé CG
Gynecol Oncol; 1992 Aug; 46(2):203-7. PubMed ID: 1379961
[TBL] [Abstract][Full Text] [Related]
18. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancer.
Zanetta G; Fei F; Parma G; Balestrino M; Lissoni A; Gabriele A; Mangioni C
Ann Oncol; 1999 Oct; 10(10):1171-4. PubMed ID: 10586332
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy in recurrent and advanced cervical cancer.
Kumar L; Bhargava VL
Gynecol Oncol; 1991 Feb; 40(2):107-11. PubMed ID: 1707022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
